Skip to main content
Premium Trial:

Request an Annual Quote

Geert Walther Nygaard, Pamela Harris

Premium
Epigenomics has announced that its supervisory board has unanimously chosen Geert Walther Nygaard as its new CEO. Nygaard will begin his new post Feb. 1.
 
Nygaard joins Epigenomics from Wiesbaden, Germany-based Abbott GmbH & Co. KG where he was managing director. He also held various positions with several diagnostics firms, including Beckman Instruments and Dako.
 

 
Panacea Pharmaceuticals announced that Pamela Harris will be its new VP of medical and clinical affairs. In this position, Harris will lead the design and conduct of clinical trials for Panacea’s therapeutic and diagnostic products for cancer and central nervous system diseases.
 
Previously, Harris was the chief medical officer at Callisto Pharmaceuticals. She also served as a team leader and senior medical director at Pfizer, as well as the director of clinical research at Wyeth Pharmaceuticals and US Bioscience.

Filed under

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.